(3R,6R,9R,12R)-3-butan-2-yl-9-(5,6-dihydroxyoctyl)-6-[(1-methoxyindol-3-yl)methyl]-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone;(3R,6R,9R,12R)-3-butan-2-yl-9-(6,7-dihydroxyoctyl)-6-[(1-methoxyindol-3-yl)methyl]-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone;6-[(3R,6R,9R,12R)-3-butan-2-yl-6-[(1-methoxyindol-3-yl)methyl]-2,5,8,11-tetraoxo-1,4,7,10-tetrazabicyclo[10.4.0]hexadecan-9-yl]-N-methoxy-N-methylhexanamide;5-[(3R,6R,9R,12R)-3-butan-2-yl-6-[(1-methoxyindol-3-yl)methyl]-2,5,8,11-tetraoxo-1,4,7,10-tetrazabicyclo[10.4.0]hexadecan-9-yl]pentanal

C133H195N21O27 — CID 157187437

IUPAC(3R,6R,9R,12R)-3-butan-2-yl-9-(5,6-dihydroxyoctyl)-6-[(1-methoxyindol-3-yl)methyl]-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone;(3R,6R,9R,12R)-3-butan-2-yl-9-(6,7-dihydroxyoctyl)-6-[(1-methoxyindol-3-yl)methyl]-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone;6-[(3R,6R,9R,12R)-3-butan-2-yl-6-[(1-methoxyindol-3-yl)methyl]-2,5,8,11-tetraoxo-1,4,7,10-tetrazabicyclo[10.4.0]hexadecan-9-yl]-N-methoxy-N-methylhexanamide;5-[(3R,6R,9R,12R)-3-butan-2-yl-6-[(1-methoxyindol-3-yl)methyl]-2,5,8,11-tetraoxo-1,4,7,10-tetrazabicyclo[10.4.0]hexadecan-9-yl]pentanal
SMILESCCC(C)[C@H]1NC(=O)[C@@H](Cc2cn(OC)c3ccccc23)NC(=O)[C@@H](CCCCC=O)NC(=O)[C@H]2CCCCN2C1=O.CCC(C)[C@H]1NC(=O)[C@@H](Cc2cn(OC)c3ccccc23)NC(=O)[C@@H](CCCCCC(=O)N(C)OC)NC(=O)[C@H]2CCCCN2C1=O.CCC(C)[C@H]1NC(=O)[C@@H](Cc2cn(OC)c3ccccc23)NC(=O)[C@@H](CCCCCC(O)C(C)O)NC(=O)[C@H]2CCCCN2C1=O.CCC(O)C(O)CCCC[C@H]1NC(=O)[C@H]2CCCCN2C(=O)[C@@H](C(C)CC)NC(=O)[C@@H](Cc2cn(OC)c3ccccc23)NC1=O
InChIInChI=1S/C34H50N6O7.2C34H51N5O7.C31H43N5O6/c1-6-22(2)30-34(45)39-19-13-12-17-28(39)33(44)35-25(15-8-7-9-18-29(41)38(3)46-4)31(42)36-26(32(43)37-30)20-23-21-40(47-5)27-16-11-10-14-24(23)27;1-5-21(2)30-34(45)38-18-12-11-16-28(38)33(44)35-25(14-7-6-8-17-29(41)22(3)40)31(42)36-26(32(43)37-30)19-23-20-39(46-4)27-15-10-9-13-24(23)27;1-5-21(3)30-34(45)38-18-12-11-16-27(38)33(44)35-24(14-8-10-17-29(41)28(40)6-2)31(42)36-25(32(43)37-30)19-22-20-39(46-4)26-15-9-7-13-23(22)26;1-4-20(2)27-31(41)35-16-10-9-15-26(35)30(40)32-23(13-6-5-11-17-37)28(38)33-24(29(39)34-27)18-21-19-36(42-3)25-14-8-7-12-22(21)25/h10-11,14,16,21-22,25-26,28,30H,6-9,12-13,15,17-20H2,1-5H3,(H,35,44)(H,36,42)(H,37,43);9-10,13,15,20-22,25-26,28-30,40-41H,5-8,11-12,14,16-19H2,1-4H3,(H,35,44)(H,36,42)(H,37,43);7,9,13,15,20-21,24-25,27-30,40-41H,5-6,8,10-12,14,16-19H2,1-4H3,(H,35,44)(H,36,42)(H,37,43);7-8,12,14,17,19-20,23-24,26-27H,4-6,9-11,13,15-16,18H2,1-3H3,(H,32,40)(H,33,38)(H,34,39)/t22?,25-,26-,28-,30-;21?,22?,25-,26-,28-,29?,30-;21?,24-,25-,27-,28?,29?,30-;20?,23-,24-,26-,27-/m1111/s1
InChIKeyAPHBSZXPTXUXCZ-QUPNKKOZSA-N
MW2520.14 g/mol
LogP7.66
Rot. Bonds46

About (3R,6R,9R,12R)-3-butan-2-yl-9-(5,6-dihydroxyoctyl)-6-[(1-methoxyindol-3-yl)methyl]-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone;(3R,6R,9R,12R)-3-butan-2-yl-9-(6,7-dihydroxyoctyl)-6-[(1-methoxyindol-3-yl)methyl]-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone;6-[(3R,6R,9R,12R)-3-butan-2-yl-6-[(1-methoxyindol-3-yl)methyl]-2,5,8,11-tetraoxo-1,4,7,10-tetrazabicyclo[10.4.0]hexadecan-9-yl]-N-methoxy-N-methylhexanamide;5-[(3R,6R,9R,12R)-3-butan-2-yl-6-[(1-methoxyindol-3-yl)methyl]-2,5,8,11-tetraoxo-1,4,7,10-tetrazabicyclo[10.4.0]hexadecan-9-yl]pentanal

(3R,6R,9R,12R)-3-butan-2-yl-9-(5,6-dihydroxyoctyl)-6-[(1-methoxyindol-3-yl)methyl]-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone;(3R,6R,9R,12R)-3-butan-2-yl-9-(6,7-dihydroxyoctyl)-6-[(1-methoxyindol-3-yl)methyl]-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone;6-[(3R,6R,9R,12R)-3-butan-2-yl-6-[(1-methoxyindol-3-yl)methyl]-2,5,8,11-tetraoxo-1,4,7,10-tetrazabicyclo[10.4.0]hexadecan-9-yl]-N-methoxy-N-methylhexanamide;5-[(3R,6R,9R,12R)-3-butan-2-yl-6-[(1-methoxyindol-3-yl)methyl]-2,5,8,11-tetraoxo-1,4,7,10-tetrazabicyclo[10.4.0]hexadecan-9-yl]pentanal (PubChem CID 157187437) has the molecular formula C133H195N21O27 and a molecular weight of 2520.14 g/mol. Its IUPAC name is (3R,6R,9R,12R)-3-butan-2-yl-9-(5,6-dihydroxyoctyl)-6-[(1-methoxyindol-3-yl)methyl]-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone;(3R,6R,9R,12R)-3-butan-2-yl-9-(6,7-dihydroxyoctyl)-6-[(1-methoxyindol-3-yl)methyl]-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone;6-[(3R,6R,9R,12R)-3-butan-2-yl-6-[(1-methoxyindol-3-yl)methyl]-2,5,8,11-tetraoxo-1,4,7,10-tetrazabicyclo[10.4.0]hexadecan-9-yl]-N-methoxy-N-methylhexanamide;5-[(3R,6R,9R,12R)-3-butan-2-yl-6-[(1-methoxyindol-3-yl)methyl]-2,5,8,11-tetraoxo-1,4,7,10-tetrazabicyclo[10.4.0]hexadecan-9-yl]pentanal.

Molecular Properties

Compound Name(3R,6R,9R,12R)-3-butan-2-yl-9-(5,6-dihydroxyoctyl)-6-[(1-methoxyindol-3-yl)methyl]-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone;(3R,6R,9R,12R)-3-butan-2-yl-9-(6,7-dihydroxyoctyl)-6-[(1-methoxyindol-3-yl)methyl]-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone;6-[(3R,6R,9R,12R)-3-butan-2-yl-6-[(1-methoxyindol-3-yl)methyl]-2,5,8,11-tetraoxo-1,4,7,10-tetrazabicyclo[10.4.0]hexadecan-9-yl]-N-methoxy-N-methylhexanamide;5-[(3R,6R,9R,12R)-3-butan-2-yl-6-[(1-methoxyindol-3-yl)methyl]-2,5,8,11-tetraoxo-1,4,7,10-tetrazabicyclo[10.4.0]hexadecan-9-yl]pentanal
PubChem CID157187437
Molecular FormulaC133H195N21O27
Molecular Weight2520.14 g/mol
Exact Mass2518.45
IUPAC Name(3R,6R,9R,12R)-3-butan-2-yl-9-(5,6-dihydroxyoctyl)-6-[(1-methoxyindol-3-yl)methyl]-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone;(3R,6R,9R,12R)-3-butan-2-yl-9-(6,7-dihydroxyoctyl)-6-[(1-methoxyindol-3-yl)methyl]-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone;6-[(3R,6R,9R,12R)-3-butan-2-yl-6-[(1-methoxyindol-3-yl)methyl]-2,5,8,11-tetraoxo-1,4,7,10-tetrazabicyclo[10.4.0]hexadecan-9-yl]-N-methoxy-N-methylhexanamide;5-[(3R,6R,9R,12R)-3-butan-2-yl-6-[(1-methoxyindol-3-yl)methyl]-2,5,8,11-tetraoxo-1,4,7,10-tetrazabicyclo[10.4.0]hexadecan-9-yl]pentanal
SMILESCCC(C)[C@H]1NC(=O)[C@@H](Cc2cn(OC)c3ccccc23)NC(=O)[C@@H](CCCCC=O)NC(=O)[C@H]2CCCCN2C1=O.CCC(C)[C@H]1NC(=O)[C@@H](Cc2cn(OC)c3ccccc23)NC(=O)[C@@H](CCCCCC(=O)N(C)OC)NC(=O)[C@H]2CCCCN2C1=O.CCC(C)[C@H]1NC(=O)[C@@H](Cc2cn(OC)c3ccccc23)NC(=O)[C@@H](CCCCCC(O)C(C)O)NC(=O)[C@H]2CCCCN2C1=O.CCC(O)C(O)CCCC[C@H]1NC(=O)[C@H]2CCCCN2C(=O)[C@@H](C(C)CC)NC(=O)[C@@H](Cc2cn(OC)c3ccccc23)NC1=O
InChIInChI=1S/C34H50N6O7.2C34H51N5O7.C31H43N5O6/c1-6-22(2)30-34(45)39-19-13-12-17-28(39)33(44)35-25(15-8-7-9-18-29(41)38(3)46-4)31(42)36-26(32(43)37-30)20-23-21-40(47-5)27-16-11-10-14-24(23)27;1-5-21(2)30-34(45)38-18-12-11-16-28(38)33(44)35-25(14-7-6-8-17-29(41)22(3)40)31(42)36-26(32(43)37-30)19-23-20-39(46-4)27-15-10-9-13-24(23)27;1-5-21(3)30-34(45)38-18-12-11-16-27(38)33(44)35-24(14-8-10-17-29(41)28(40)6-2)31(42)36-25(32(43)37-30)19-22-20-39(46-4)26-15-9-7-13-23(22)26;1-4-20(2)27-31(41)35-16-10-9-15-26(35)30(40)32-23(13-6-5-11-17-37)28(38)33-24(29(39)34-27)18-21-19-36(42-3)25-14-8-7-12-22(21)25/h10-11,14,16,21-22,25-26,28,30H,6-9,12-13,15,17-20H2,1-5H3,(H,35,44)(H,36,42)(H,37,43);9-10,13,15,20-22,25-26,28-30,40-41H,5-8,11-12,14,16-19H2,1-4H3,(H,35,44)(H,36,42)(H,37,43);7,9,13,15,20-21,24-25,27-30,40-41H,5-6,8,10-12,14,16-19H2,1-4H3,(H,35,44)(H,36,42)(H,37,43);7-8,12,14,17,19-20,23-24,26-27H,4-6,9-11,13,15-16,18H2,1-3H3,(H,32,40)(H,33,38)(H,34,39)/t22?,25-,26-,28-,30-;21?,22?,25-,26-,28-,29?,30-;21?,24-,25-,27-,28?,29?,30-;20?,23-,24-,26-,27-/m1111/s1
InChIKeyAPHBSZXPTXUXCZ-QUPNKKOZSA-N
XLogP7.66
TPSA614.61 Ų
H-Bond Donors16
H-Bond Acceptors31
Rotatable Bonds46
Heavy Atoms181
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002520.14
LogP ≤ 57.66
H-Bond Donors ≤ 516
H-Bond Acceptors ≤ 1031

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze (3R,6R,9R,12R)-3-butan-2-yl-9-(5,6-dihydroxyoctyl)-6-[(1-methoxyindol-3-yl)methyl]-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone;(3R,6R,9R,12R)-3-butan-2-yl-9-(6,7-dihydroxyoctyl)-6-[(1-methoxyindol-3-yl)methyl]-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone;6-[(3R,6R,9R,12R)-3-butan-2-yl-6-[(1-methoxyindol-3-yl)methyl]-2,5,8,11-tetraoxo-1,4,7,10-tetrazabicyclo[10.4.0]hexadecan-9-yl]-N-methoxy-N-methylhexanamide;5-[(3R,6R,9R,12R)-3-butan-2-yl-6-[(1-methoxyindol-3-yl)methyl]-2,5,8,11-tetraoxo-1,4,7,10-tetrazabicyclo[10.4.0]hexadecan-9-yl]pentanal with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (3R,6R,9R,12R)-3-butan-2-yl-9-(5,6-dihydroxyoctyl)-6-[(1-methoxyindol-3-yl)methyl]-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone;(3R,6R,9R,12R)-3-butan-2-yl-9-(6,7-dihydroxyoctyl)-6-[(1-methoxyindol-3-yl)methyl]-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone;6-[(3R,6R,9R,12R)-3-butan-2-yl-6-[(1-methoxyindol-3-yl)methyl]-2,5,8,11-tetraoxo-1,4,7,10-tetrazabicyclo[10.4.0]hexadecan-9-yl]-N-methoxy-N-methylhexanamide;5-[(3R,6R,9R,12R)-3-butan-2-yl-6-[(1-methoxyindol-3-yl)methyl]-2,5,8,11-tetraoxo-1,4,7,10-tetrazabicyclo[10.4.0]hexadecan-9-yl]pentanal?
The IUPAC name of (3R,6R,9R,12R)-3-butan-2-yl-9-(5,6-dihydroxyoctyl)-6-[(1-methoxyindol-3-yl)methyl]-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone;(3R,6R,9R,12R)-3-butan-2-yl-9-(6,7-dihydroxyoctyl)-6-[(1-methoxyindol-3-yl)methyl]-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone;6-[(3R,6R,9R,12R)-3-butan-2-yl-6-[(1-methoxyindol-3-yl)methyl]-2,5,8,11-tetraoxo-1,4,7,10-tetrazabicyclo[10.4.0]hexadecan-9-yl]-N-methoxy-N-methylhexanamide;5-[(3R,6R,9R,12R)-3-butan-2-yl-6-[(1-methoxyindol-3-yl)methyl]-2,5,8,11-tetraoxo-1,4,7,10-tetrazabicyclo[10.4.0]hexadecan-9-yl]pentanal (CID 157187437) is (3R,6R,9R,12R)-3-butan-2-yl-9-(5,6-dihydroxyoctyl)-6-[(1-methoxyindol-3-yl)methyl]-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone;(3R,6R,9R,12R)-3-butan-2-yl-9-(6,7-dihydroxyoctyl)-6-[(1-methoxyindol-3-yl)methyl]-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone;6-[(3R,6R,9R,12R)-3-butan-2-yl-6-[(1-methoxyindol-3-yl)methyl]-2,5,8,11-tetraoxo-1,4,7,10-tetrazabicyclo[10.4.0]hexadecan-9-yl]-N-methoxy-N-methylhexanamide;5-[(3R,6R,9R,12R)-3-butan-2-yl-6-[(1-methoxyindol-3-yl)methyl]-2,5,8,11-tetraoxo-1,4,7,10-tetrazabicyclo[10.4.0]hexadecan-9-yl]pentanal.
What is the SMILES notation for (3R,6R,9R,12R)-3-butan-2-yl-9-(5,6-dihydroxyoctyl)-6-[(1-methoxyindol-3-yl)methyl]-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone;(3R,6R,9R,12R)-3-butan-2-yl-9-(6,7-dihydroxyoctyl)-6-[(1-methoxyindol-3-yl)methyl]-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone;6-[(3R,6R,9R,12R)-3-butan-2-yl-6-[(1-methoxyindol-3-yl)methyl]-2,5,8,11-tetraoxo-1,4,7,10-tetrazabicyclo[10.4.0]hexadecan-9-yl]-N-methoxy-N-methylhexanamide;5-[(3R,6R,9R,12R)-3-butan-2-yl-6-[(1-methoxyindol-3-yl)methyl]-2,5,8,11-tetraoxo-1,4,7,10-tetrazabicyclo[10.4.0]hexadecan-9-yl]pentanal?
The canonical SMILES for (3R,6R,9R,12R)-3-butan-2-yl-9-(5,6-dihydroxyoctyl)-6-[(1-methoxyindol-3-yl)methyl]-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone;(3R,6R,9R,12R)-3-butan-2-yl-9-(6,7-dihydroxyoctyl)-6-[(1-methoxyindol-3-yl)methyl]-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone;6-[(3R,6R,9R,12R)-3-butan-2-yl-6-[(1-methoxyindol-3-yl)methyl]-2,5,8,11-tetraoxo-1,4,7,10-tetrazabicyclo[10.4.0]hexadecan-9-yl]-N-methoxy-N-methylhexanamide;5-[(3R,6R,9R,12R)-3-butan-2-yl-6-[(1-methoxyindol-3-yl)methyl]-2,5,8,11-tetraoxo-1,4,7,10-tetrazabicyclo[10.4.0]hexadecan-9-yl]pentanal is CCC(C)[C@H]1NC(=O)[C@@H](Cc2cn(OC)c3ccccc23)NC(=O)[C@@H](CCCCC=O)NC(=O)[C@H]2CCCCN2C1=O.CCC(C)[C@H]1NC(=O)[C@@H](Cc2cn(OC)c3ccccc23)NC(=O)[C@@H](CCCCCC(=O)N(C)OC)NC(=O)[C@H]2CCCCN2C1=O.CCC(C)[C@H]1NC(=O)[C@@H](Cc2cn(OC)c3ccccc23)NC(=O)[C@@H](CCCCCC(O)C(C)O)NC(=O)[C@H]2CCCCN2C1=O.CCC(O)C(O)CCCC[C@H]1NC(=O)[C@H]2CCCCN2C(=O)[C@@H](C(C)CC)NC(=O)[C@@H](Cc2cn(OC)c3ccccc23)NC1=O.
What is the InChIKey of (3R,6R,9R,12R)-3-butan-2-yl-9-(5,6-dihydroxyoctyl)-6-[(1-methoxyindol-3-yl)methyl]-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone;(3R,6R,9R,12R)-3-butan-2-yl-9-(6,7-dihydroxyoctyl)-6-[(1-methoxyindol-3-yl)methyl]-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone;6-[(3R,6R,9R,12R)-3-butan-2-yl-6-[(1-methoxyindol-3-yl)methyl]-2,5,8,11-tetraoxo-1,4,7,10-tetrazabicyclo[10.4.0]hexadecan-9-yl]-N-methoxy-N-methylhexanamide;5-[(3R,6R,9R,12R)-3-butan-2-yl-6-[(1-methoxyindol-3-yl)methyl]-2,5,8,11-tetraoxo-1,4,7,10-tetrazabicyclo[10.4.0]hexadecan-9-yl]pentanal?
The InChIKey is APHBSZXPTXUXCZ-QUPNKKOZSA-N. The full InChI is InChI=1S/C34H50N6O7.2C34H51N5O7.C31H43N5O6/c1-6-22(2)30-34(45)39-19-13-12-17-28(39)33(44)35-25(15-8-7-9-18-29(41)38(3)46-4)31(42)36-26(32(43)37-30)20-23-21-40(47-5)27-16-11-10-14-24(23)27;1-5-21(2)30-34(45)38-18-12-11-16-28(38)33(44)35-25(14-7-6-8-17-29(41)22(3)40)31(42)36-26(32(43)37-30)19-23-20-39(46-4)27-15-10-9-13-24(23)27;1-5-21(3)30-34(45)38-18-12-11-16-27(38)33(44)35-24(14-8-10-17-29(41)28(40)6-2)31(42)36-25(32(43)37-30)19-22-20-39(46-4)26-15-9-7-13-23(22)26;1-4-20(2)27-31(41)35-16-10-9-15-26(35)30(40)32-23(13-6-5-11-17-37)28(38)33-24(29(39)34-27)18-21-19-36(42-3)25-14-8-7-12-22(21)25/h10-11,14,16,21-22,25-26,28,30H,6-9,12-13,15,17-20H2,1-5H3,(H,35,44)(H,36,42)(H,37,43);9-10,13,15,20-22,25-26,28-30,40-41H,5-8,11-12,14,16-19H2,1-4H3,(H,35,44)(H,36,42)(H,37,43);7,9,13,15,20-21,24-25,27-30,40-41H,5-6,8,10-12,14,16-19H2,1-4H3,(H,35,44)(H,36,42)(H,37,43);7-8,12,14,17,19-20,23-24,26-27H,4-6,9-11,13,15-16,18H2,1-3H3,(H,32,40)(H,33,38)(H,34,39)/t22?,25-,26-,28-,30-;21?,22?,25-,26-,28-,29?,30-;21?,24-,25-,27-,28?,29?,30-;20?,23-,24-,26-,27-/m1111/s1.
What are the key properties of (3R,6R,9R,12R)-3-butan-2-yl-9-(5,6-dihydroxyoctyl)-6-[(1-methoxyindol-3-yl)methyl]-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone;(3R,6R,9R,12R)-3-butan-2-yl-9-(6,7-dihydroxyoctyl)-6-[(1-methoxyindol-3-yl)methyl]-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone;6-[(3R,6R,9R,12R)-3-butan-2-yl-6-[(1-methoxyindol-3-yl)methyl]-2,5,8,11-tetraoxo-1,4,7,10-tetrazabicyclo[10.4.0]hexadecan-9-yl]-N-methoxy-N-methylhexanamide;5-[(3R,6R,9R,12R)-3-butan-2-yl-6-[(1-methoxyindol-3-yl)methyl]-2,5,8,11-tetraoxo-1,4,7,10-tetrazabicyclo[10.4.0]hexadecan-9-yl]pentanal?
(3R,6R,9R,12R)-3-butan-2-yl-9-(5,6-dihydroxyoctyl)-6-[(1-methoxyindol-3-yl)methyl]-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone;(3R,6R,9R,12R)-3-butan-2-yl-9-(6,7-dihydroxyoctyl)-6-[(1-methoxyindol-3-yl)methyl]-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone;6-[(3R,6R,9R,12R)-3-butan-2-yl-6-[(1-methoxyindol-3-yl)methyl]-2,5,8,11-tetraoxo-1,4,7,10-tetrazabicyclo[10.4.0]hexadecan-9-yl]-N-methoxy-N-methylhexanamide;5-[(3R,6R,9R,12R)-3-butan-2-yl-6-[(1-methoxyindol-3-yl)methyl]-2,5,8,11-tetraoxo-1,4,7,10-tetrazabicyclo[10.4.0]hexadecan-9-yl]pentanal has a molecular weight of 2520.14 g/mol, XLogP of 7.66, 46 rotatable bonds, 16 hydrogen bond donors, and 31 hydrogen bond acceptors.
Where does this data come from?
All data for (3R,6R,9R,12R)-3-butan-2-yl-9-(5,6-dihydroxyoctyl)-6-[(1-methoxyindol-3-yl)methyl]-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone;(3R,6R,9R,12R)-3-butan-2-yl-9-(6,7-dihydroxyoctyl)-6-[(1-methoxyindol-3-yl)methyl]-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone;6-[(3R,6R,9R,12R)-3-butan-2-yl-6-[(1-methoxyindol-3-yl)methyl]-2,5,8,11-tetraoxo-1,4,7,10-tetrazabicyclo[10.4.0]hexadecan-9-yl]-N-methoxy-N-methylhexanamide;5-[(3R,6R,9R,12R)-3-butan-2-yl-6-[(1-methoxyindol-3-yl)methyl]-2,5,8,11-tetraoxo-1,4,7,10-tetrazabicyclo[10.4.0]hexadecan-9-yl]pentanal is sourced from PubChem (CID 157187437), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).